Literature DB >> 6542729

Clinical evaluation of amitraz as a treatment for canine demodicosis.

S D Folz, T J Kakuk, C L Henke, D L Rector, F B Tesar.   

Abstract

A liquid concentrate formulation of amitraz was clinically evaluated in 1721 canines showing demodicosis, by 25 veterinary investigators. The therapy was applied topically at 14-day intervals, and at a concentration of 250 ppm active drug in water. The miticide was efficacious and safe; approximately 99% of the canines showing localized or generalized demodicosis became clinically normal, and the side-effects recorded were minimal and transient. Approximately 3/4 of the patients were pure-bred animals and the majority were less than 1 year old. The clinical data support the conclusion that amitraz (liquid concentrate) is efficacious and safe for treating canine demodicosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542729     DOI: 10.1016/0304-4017(84)90051-7

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  6 in total

1.  In vitro efficacy of amitraz, coumaphos, deltamethrin and lindane against engorged female Rhipicephalus (Boophilus) annulatus and Haemaphysalis bispinosa ticks.

Authors:  Reghu Ravindran; Gopi Jyothimol; Krishnan Kavillimakkil Amithamol; Athalathil Ramankutty Sunil; Leena Chandrasekhar; Dibya Ranjan Lenka; Achuthkumar Amritha; Kanapadinchareveetil Sreelekha; Nanjundappa Sathish; Darsana Udayan; Thumadath Palayullaparambil Adarsh Krishna; Thirumangalath Meethal Divya; Sanis Juliet; Karapparambu Gopalan Ajith Kumar; Suresh Narayanan Nair; Srikanta Ghosh
Journal:  Exp Appl Acarol       Date:  2018-05-08       Impact factor: 2.132

2.  The main factors influencing canine demodicosis treatment outcome and determination of optimal therapy.

Authors:  Milica Arsenović; Lato Pezo; Nebojša Vasić; Rodoljub Ćirić; Milan Stefanović
Journal:  Parasitol Res       Date:  2015-05-28       Impact factor: 2.289

3.  Efficacy of a topical application of Certifect® (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5.63% w/v) for the treatment of canine generalized demodicosis.

Authors:  Josephus Fourie; Pascal Dumont; Lénaïg Halos; Frederic Beugnet; Matthias Pollmeier
Journal:  Parasite       Date:  2013-11-21       Impact factor: 3.000

4.  Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.

Authors:  Frédéric Beugnet; Lénaïg Halos; Diane Larsen; Christa de Vos
Journal:  Parasite       Date:  2016-03-24       Impact factor: 3.000

Review 5.  Amitraz, an underrecognized poison: A systematic review.

Authors:  Sahajal Dhooria; Ritesh Agarwal
Journal:  Indian J Med Res       Date:  2016-09       Impact factor: 2.375

6.  Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.

Authors:  Wilfried Lebon; Massimo Beccati; Patrick Bourdeau; Thomas Brement; Vincent Bruet; Agnieszka Cekiera; Odile Crosaz; Céline Darmon; Jacques Guillot; Marion Mosca; Didier Pin; Jaroslaw Popiel; Dorota Pomorska Handwerker; Diane Larsen; Eric Tielemans; Frédéric Beugnet; Lénaïg Halos
Journal:  Parasit Vectors       Date:  2018-09-10       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.